News – Page 38 – Endpoints News

OpenAI meets cancer care

3 months ago

Verve is latest gene editing company to suffer setback, as Vertex walks away from pact

3 months ago

Teladoc reports $1B net loss as it works to turn around its business

3 months ago

Hansoh ends collaboration with Silence; Vir hunts for HBV drug partner

3 months ago

Can Bill Anderson save Bayer?

3 months ago

Merck mulls new site in Delaware; Granules India buys peptide CDMO

3 months ago

Kallyope quietly reports Phase 2 obesity data, begins mid-stage migraine trial

3 months ago

Startup working on oral antibodies shares early ulcerative colitis data

3 months ago

FDA meeting to pick next winter's flu shot is canceled, in ominous sign for US vaccine policy

3 months ago

Medicare spending on common diabetes drugs skyrocketed, HHS inspector general finds

3 months ago

After rejection, Regeneron seeks accelerated approval of bispecific for only one of two types of lymphoma

3 months ago

AstraZeneca’s SERD hits primary endpoint in late-stage trial, but first-line potential remains uncertain

3 months ago

Regeneron, two Chinese biotechs tout promise of their hearing loss gene therapies

3 months ago

Harbour BioMed inks deal up to $395M; ORIC refines plans for two drugs

3 months ago

Updated: Lilly joins Trump administration to announce $27B manufacturing commitment

3 months ago

Ginkgo uncertain over the future of US government funding, stock drops

3 months ago

Merck says Keytruda could be up next for IRA price cuts

3 months ago

Eikon Therapeutics raises $351M Series D as lead drug starts Phase 3

3 months ago

Court orders CVS to comply with the FTC’s PBM-related investigation

3 months ago

Leo Pharma says its yearslong makeover is about to pay off

3 months ago

Candel's viral therapy shows promising survival in small pancreatic cancer study

3 months ago

Compounders sue FDA over removal of semaglutide from official shortage list

3 months ago

Chicago biotech Emalex says it cleared a Phase 3 for Tourette syndrome, will seek FDA approval

3 months ago

Boehringer Ingelheim wins jury verdict in Zantac retrial in Illinois

3 months ago

First page Previous page 35 36 373839 40 41 Next page Last page